Chinese Pharmaceuticals & Biotech Undervalued Dividend Payers

Yunnan Baiyao GroupLtd

Market Cap: CN¥88.0b

Engages in the sale of pharmaceuticals, medicinal materials, health and daily chemical products in China.

China Resources Sanjiu Medical & Pharmaceutical

Market Cap: CN¥40.2b

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.

Beijing Tongrentang

Market Cap: CN¥32.6b

Engages in the production and sale of traditional Chinese medicine preparations in China and internationally.

Dong-E-E-Jiao

Market Cap: CN¥30.9b

Engages in the research, development, production, and sale of donkey-hide gelatin and related products in China and internationally.

Livzon Pharmaceutical Group

Market Cap: CN¥23.6b

Researches, develops, produces, exports, and sells pharmaceutical products, and active pharmaceutical ingredients (API) and intermediates in the People’s Republic of China and internationally.

Tasly Pharmaceutical Group

Market Cap: CN¥22.4b

Engages in the research, development, production, and sale of pharmaceuticals in China.

China Resources Jiangzhong PharmaceuticalLtd

Market Cap: CN¥15.5b

Engages in the manufacture of pharmaceutical products in China.

Tianjin Ringpu Bio-TechnologyLtd

Market Cap: CN¥8.1b

Engages in the research and development, production, and sale of veterinary raw materials, pharmaceutical preparation, functional additives, and veterinary biological products.

Amoy Diagnostics

Market Cap: CN¥7.3b

Engages in research and development, production, sale, and supporting services of tumor precision medical diagnostic products in China and internationally.